Gabriel Capellá
Gabriel Capellá is the Director of the Hereditary Cancer Program, at the Catalan Institute of Oncology since 2010, where he was Director of the Translational Research Laboratory until 2011. His main interest is the study of the genetic basis of gastrointestinal cancer focusing in novel technologies for the clinical management of patient at risk of developing GI Cancer. He has served as Vice-Director for Research and Innovation, Health Department, Catalan Government and he is currently the Director of the Bellvitge Biomedical Research Institute (IDIBELL). He is co-founder of VCN Biosciences, an spin-off aimed at developing new cancer therapies based on oncolytic adenoviruses.